Xinyuan Zhang - Concepedia

Author

Xinyuan Zhang

United States Food and Drug Administration ORCID

Also Known As

Wu, Yun, X Y Zhang, X Zhang, Xin-Yuan Zhang, Xin-yuan Zhang, Xinyuan Zhang, Zhang X, Zhang Xinyuan, Zhang, Xinyuan

209

Publications

5.2K

Citations

H-Index

139

Concepts

All Affiliations

United States Food and Drug Administration Center for Drug Evaluation and Research University of Michigan Chongqing Medical University China International Science and Technology Cooperation

About

Xinyuan Zhang is an author at United States Food and Drug Administration specializing in medicine, pharmacology, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	35	2.1K
2	Engineering	12	14	913
3	Health Sciences	4	4	149
4	Natural Sciences	1	1	12
5	Public Health	1	1	105

Xinyuan Zhang

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
Carboxylation as an initial reaction in the anaerobic metabolism of naphthalene and phenanthrene by sulfidogenic consortia Xinyuan Zhang, L. Y. Young Applied and Environmental Microbiology EngineeringDegradation ReactionOrganic ChemistryPah DegradationAnaerobic Digestion	1997	325
Physiologically Based Pharmacokinetic Modeling in Regulatory Science: An Update From the U.S. Food and Drug Administration’s Office of Clinical Pharmacology Manuela Grimstein, Yuching Yang, Xinyuan Zhang, Journal of Pharmaceutical Sciences Physiologically Based PharmacokineticsPharmacokinetic ModelingPharmacodynamicsU.s. FoodMedicine	2018	304
Circulating Levels of the Short-Chain Fatty Acid Acetate Mediate the Effect of the Gut Microbiome on Visceral Fat Ana Nogal, Panayiotis Louca, Xinyuan Zhang, Frontiers in Microbiology	2021	186
Application of PBPK Modeling and Simulation for Regulatory Decision Making and Its Impact on US Prescribing Information: An Update on the 2018‐2019 Submissions to the US FDA's Office of Clinical Pharmacology Xinyuan Zhang, Yuching Yang, Manuela Grimstein, The Journal of Clinical Pharmacology	2020	178
FDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast Cancer Preeti Narayan, Tatiana M. Prowell, Jennifer Gao, Clinical Cancer Research	2020	157
Consideration of a Credibility Assessment Framework in Model‐Informed Drug Development: Potential Application to Physiologically‐Based Pharmacokinetic Modeling and Simulation Colleen Kuemmel, Yuching Yang, Xinyuan Zhang, CPT Pharmacometrics & Systems Pharmacology	2019	151
Utility of Physiologically Based Absorption Modeling in Implementing Quality by Design in Drug Development Xinyuan Zhang, Robert Lionberger, Barbara M. Davit, The AAPS Journal Physiologically Based PharmacokineticsDrug DesignDrug DiscoveryBioanalysisMedicine	2011	127
Identification of ribosomal protein S25 (RPS25)–MDM2–p53 regulatory feedback loop Xinyuan Zhang, Wenjing Wang, Hua Wang, Oncogene Molecular BiologyCancer GeneticsRibosomal Protein S25	2012	110
Peptides, new tools for plant protection in eco-agriculture Yimeng Zhang, Dexing Ye, Yan Liu, Advanced Agrochem New ToolsEngineeringPlant Defence ActivatorBotanyBiochemistry	2023	105
Novel Role of Resveratrol Wei Xu, Yang Lü, Jihong Yao, Shock	2014	102

Page 1